
McKesson Announces $2.25 Billion Acquisition of Precision Medicine Group
The healthcare distribution giant is expanding its specialty pharmacy and patient services portfolio through a major cash-and-stock deal valued at $2.25 billion.
3 stories found

The healthcare distribution giant is expanding its specialty pharmacy and patient services portfolio through a major cash-and-stock deal valued at $2.25 billion.

Major healthcare distributor McKesson has finalized its purchase of Precision Medicine Group for $2.25 billion, expanding its portfolio in specialized pharmaceutical and patient support services.

McKesson has announced its acquisition of Precision Medicine Group in a deal valued at $2.25 billion. This strategic move strengthens McKesson's position in clinical research and precision medicine.